ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
6,051.09
0.00%
Dow Jones
43,828.06
-0.20%
US Dollar vs MXN
20.12055
-0.05%
Brent Oil
74.255
0.16%
Bitcoin
104,502.19
3.06%
Pepperstone
Advertisement
Registration Strip Icon for default Regístrate gratis para obtener cotizaciones en tiempo real, gráficos interactivos, flujo de opciones en vivo y más.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Reino Unido
  5. LSE
  6. Alligator Bioscience Ab (0RK9)

  7. Alligator Bioscience Ab (0RK9) Noticias

0RK9

Alligator Bioscience Ab (0RK9)

Alligator Bioscience Ab
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:LSE:0RK9
FechaHoraFuenteTítuloSímboloCompañía
01/04/202201:20PR Newswire (US)Alligator Bioscience Announces Completion of 600 mg Dose Cohort for ATOR-1017, Dose-escalation and Enrollment for 900 mg dose Cohort CommencesLSE:0RK9Alligator Bioscience Ab
23/03/202203:07PR Newswire (US)Alligator Bioscience Announces mitazalimab OPTIMIZE-1 Trial Update: Successful Completion of Phase Ib, Phase II enrolling at 900 µg/kgLSE:0RK9Alligator Bioscience Ab
11/02/202201:23PR Newswire (US)Alligator Bioscience AB: Year End report January-December 2021LSE:0RK9Alligator Bioscience Ab
01/02/202202:16PR Newswire (US)Alligator Bioscience Appoints Sumeet Ambarkhane MD as Chief Medical OfficerLSE:0RK9Alligator Bioscience Ab
19/01/202201:42PR Newswire (US)Alligator Bioscience Announces Commencement of a Sponsored Research Agreement with the University of Pennsylvania Led by Dr. Gregory BeattyLSE:0RK9Alligator Bioscience Ab
18/01/202201:19PR Newswire (US)Alligator Bioscience Announces OPTIMIZE-1 Trial Update: Cohort Fully Dosed with No Adverse Effects ReportedLSE:0RK9Alligator Bioscience Ab
16/12/202101:41PR Newswire (US)Alligator Bioscience Announces Trial Update and Early Readout for ATOR-1017 Confirming Biomarker, Safety & Tolerability DataLSE:0RK9Alligator Bioscience Ab
15/12/202107:37PR Newswire (US)Alligator Bioscience & Aptevo Therapeutics Announce Co-Publication in Peer-Reviewed Journal Nature CommunicationLSE:0RK9Alligator Bioscience Ab
08/11/202110:54PR Newswire (US)Alligator Bioscience Announces Commencement of Investigator Initiated Phase I Clinical Trial at Erasmus University RotterdamLSE:0RK9Alligator Bioscience Ab
08/11/202109:59PR Newswire (US)Bulletin from the extraordinary general meeting in Alligator Bioscience ABLSE:0RK9Alligator Bioscience Ab
21/10/202101:45PR Newswire (US)Alligator Bioscience AB: Interim report January-September 2021LSE:0RK9Alligator Bioscience Ab
07/10/202101:25PR Newswire (US)Notice of extraordinary general meeting in Alligator Bioscience ABLSE:0RK9Alligator Bioscience Ab
02/09/202105:17PR Newswire (US)Alligator is exploring financing alternatives to support phase II studies for Mitazalimab, phase II preparations for ATOR-1017 as well as the development of other pipelineLSE:0RK9Alligator Bioscience Ab
02/09/202103:33PR Newswire (US)Positive Results from the Scandion Oncology and Alligator Bioscience Collaboration Further Supports Efficacy of Mitazalimab in Combination TherapyLSE:0RK9Alligator Bioscience Ab
18/08/202101:50PR Newswire (US)Alligator Bioscience announces Immuno-oncology Research Collaboration and License Agreement with Orion CorporationLSE:0RK9Alligator Bioscience Ab
16/08/202108:16PR Newswire (US)Alligator Bioscience Announces New Senior Director of Communications & Investor RelationsLSE:0RK9Alligator Bioscience Ab
30/06/202102:10PR Newswire (US)Alligator Bioscience AB and Scandion Oncology A/S present promising preclinical dataLSE:0RK9Alligator Bioscience Ab
07/06/202101:25PR Newswire (US)Article on CD40 agonistic antibodies published in Expert Opinion on Biological TherapyLSE:0RK9Alligator Bioscience Ab
04/06/202101:20PR Newswire (US)Alligator Bioscience presents positive Phase I data at ASCO for its 4-1BB agonist drug candidate ATOR-1017LSE:0RK9Alligator Bioscience Ab
05/05/202101:23PR Newswire (US)Alligator's mitazalimab shown to enhance cancer vaccineLSE:0RK9Alligator Bioscience Ab
04/05/202101:21PR Newswire (US)Alligator Bioscience and BioArctic enter into research agreement in the neurodegenerative fieldLSE:0RK9Alligator Bioscience Ab
27/04/202101:25PR Newswire (US)Alligator Bioscience AB: Interim report January-March 2021LSE:0RK9Alligator Bioscience Ab
22/04/202112:46PR Newswire (US)The Nomination Committee's proposal regarding the board of directors ahead of the annual general meeting 2021 in Alligator Bi...LSE:0RK9Alligator Bioscience Ab
15/04/202101:21PR Newswire (US)Alligator Bioscience and MacroGenics Enter into a Research Collaboration to Develop a Novel ImmunotherapyLSE:0RK9Alligator Bioscience Ab
03/04/202107:02PR Newswire (US)Alligator Bioscience postpones the Annual General Meeting to June 1, 2021LSE:0RK9Alligator Bioscience Ab
18/03/202113:13PR Newswire (US)Alligator Bioscience appoints Søren Bregenholt as new CEOLSE:0RK9Alligator Bioscience Ab
18/03/202110:40PR Newswire (US)Alligator Bioscience publishes Annual Report for 2020LSE:0RK9Alligator Bioscience Ab
11/03/202101:21PR Newswire (US)Mitazalimab synergizes with chemotherapy - Alligator Bioscience presents new preclinical data at AACRLSE:0RK9Alligator Bioscience Ab
26/02/202101:27PR Newswire (US)Alligator Bioscience AB: Year-end Report January-December 2020LSE:0RK9Alligator Bioscience Ab
23/02/202109:12PR Newswire (US)Alligator Bioscience AB: Last day of trading in paid subscription shares (Sw. BTA)LSE:0RK9Alligator Bioscience Ab
 Showing the most relevant articles for your search:LSE:0RK9

Su Consulta Reciente

NYSE
MCD
McDonalds
USOTC
BNPQY
BNP Paribas (QX)
CCOM
SILVER
SILVER
COIN
ETHUSD
Ethereum
CCOM
US30
US 30
AMEX
XLV
Health Care Select Sector
NYSE
NKE
Nike
NASDAQ
MSFT
Microsoft
COIN
DOGEUSD
Dogecoin
NYSE
JPM
JP Morgan Chase
FX
EURMXN
Euro vs MXN
COIN
AVAXUSD
Avalanche
PM
XAUUSD
Gold vs US Dollar
USI
USTECH100
US Tech 100
COIN
ADAUSD
Cardano
NASDAQ
AMZN
Amazon.com
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados